← Back to all trials
Active Not Recruiting
NCT03085147
A Dye for the Detection of Cancer of the Tongue and Mouth
Conditions: Oral Squamous Cell Carcinoma (OSCC)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 23
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge New Jersey
Summary
The purpose of this study is to test if an investigational dye, called PARPi-FL, can be used to detect this type of cancer. This will be the first time that PARPi-FL is being tried in people. First, the investigators will test the safety of PARPi-FL at different doses to find out what effects, if any, it has on people. The investigators will also see which amount of PARPi-FL is best suited to detect cancers of the mouth and tongue.
Eligibility Criteria
Inclusion Criteria:
* Patient is ≥ 18 years old
* Histologically or cytologically proven squamous cell carcinoma of the oral cavity or pharynx (OSCC)
* Scheduled to undergo surgery at MSK
* Any tumor stage, any N, M0
* ECOG performance status 0 or 1
Exclusion Criteria:
* Any surgical therapy in the area of the oral cavity or pharynx within the last 2 weeks
* Prior or ongoing treatment with a PARP1 inhibitor
* Known hypersensitivity to Olaparib
* Known hypersensitivity to PEG Eligibility criteria will be assessed by an experienced oral surgeon, typically the Co-PI of the study.
Source: ClinicalTrials.gov (NCT03085147). StuddyBuddy aggregates publicly available trial information.